Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Clin Chem. 2013 Jan 3;59(3):557–565. doi: 10.1373/clinchem.2012.194167

Table 3.

Risk of incident diabetes according to baseline concentration of NT-proBNP.

Adjusted Risk of Incident Type 2 Diabetes
Model Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-trend Per 1 unit SD*
NT-proBNP range (ng/L) <37.4 37.4 to < 64.2 64.2 to < 117.0 ≥117.4
Model 1 1.0 0.56 (0.40–0.78) 0.61 (0.43–0.85) 0.40 (0.27–0.60) <0.001 0.68 (0.58–0.79)
P-value 0.0006 0.004 <0.0001 <0.001
Model 2 1.0 0.84 (0.56–1.26) 0.93 (0.61–1.42) 0.54 (0.33–0.89) 0.047 0.79 (0.67–0.94)
P-value 0.40 0.75 0.015 0.007
Model 3 1.0 0.88 (0.58–1.34) 0.97 (0.62–1.51) 0.51 (0.30–0.86) 0.041 0.78 (0.65–0.93)
P-value 0.56 0.89 0.011 0.006
Model 4 1.0 0.96 (0.63–1.47) 0.99 (0.63–1.56) 0.58 (0.35–0.97) 0.10 0.80 (0.67–0.96)
P-value 0.86 0.97 0.039 0.016

Model 1: Age and race adjusted

Model 2: Model 1 plus BMI (kg/m2) and BMI squared

Model 3: Model 2 plus eGFR, hormone therapy use, family history of diabetes, exercise at least once per week, alcohol use at least 1 drink per day.

Model 4: Model 3 plus insulin (μIU/mL)

Abbreviations: SD, standard deviation

*

Per 1 unit standard deviation (SD) of the natural logarithm-transformed NT-proBNP value.